Bristol-Myers Squibb (BMY) Ownership - Who owns Bristol-Myers Squibb?
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMY showed earnings on July 31, 2025. You can read more about the earnings report here.